Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 613293, 12 pages
http://dx.doi.org/10.1155/2014/613293
Research Article

In Silico Approach towards Designing Virtual Oligopeptides for HRSV

DBT-Bioinformatics Centre, Computational Biology Lab, Department of Bioinformatics, Bharathiar University, Coimbatore, Tamil Nadu 641 046, India

Received 9 July 2014; Revised 16 September 2014; Accepted 24 September 2014; Published 27 November 2014

Academic Editor: Peirong Jiao

Copyright © 2014 Ruchi Jain and Shanmughavel Piramanayagam. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. B. Hall, G. A. Weinberg, M. K. Iwane et al., “The Burden of respiratory syncytial virus infection in young children,” The New England Journal of Medicine, vol. 360, no. 6, pp. 588–598, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. K. Shay, R. C. Holman, G. E. Roosevelt, M. J. Clarke, and L. J. Anderson, “Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979–1997,” The Journal of Infectious Diseases, vol. 183, no. 1, pp. 16–22, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. W. W. Thompson, D. K. Shay, E. Weintraub et al., “Mortality associated with influenza and respiratory syncytial virus in the United States,” Journal of the American Medical Association, vol. 289, no. 2, pp. 179–186, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. K. Singh, B. Jain, A. K. Verma et al., “Hospital outbreak of human respiratory syncytial virus (HRSV) illness in immunocompromised hospitalized children during summer,” The Clinical Respiratory Journal, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Nair, D. J. Nokes, B. D. Gessner et al., “Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis,” The Lancet, vol. 375, no. 9725, pp. 1545–1555, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Leyssen, E. de Clercq, and J. Neyts, “Molecular strategies to inhibit the replication of RNA viruses,” Antiviral Research, vol. 78, no. 1, pp. 9–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. R. W. Sidwell and D. L. Barnard, “Respiratory syncytial virus infections: recent prospects for control,” Antiviral Research, vol. 71, no. 2-3, pp. 379–390, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. C. Johnson, G. A. Oliver, V. G. Prince et al., “Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus,” The Journal of Infectious Diseases, vol. 176, no. 5, pp. 1215–1224, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Wu, D. S. Pfarr, G. A. Losonsky, and P. A. Kiener, “Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab,” Current Topics in Microbiology and Immunology, vol. 317, pp. 103–123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Simoes, X. Carbonell, G. Losonsky et al., “Phase III trial of motavizumab , an enhanced potency respiratory syncytial virus (HRSV)-specific monoclonal antibody for the prevention of serious HRSV disease in high risk infants,” Acta Paediatrica, vol. 96, pp. 232–233, 2007. View at Google Scholar
  11. H. Wu, D. S. Pfarr, S. Johnson et al., “Development of motavizumab , an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract,” Journal of Molecular Biology, vol. 368, no. 3, pp. 652–665, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Young, “FDA: MedImmunes Rezield has 3x allergic reactions as Synagis,” BioWorld Today, vol. 21, no. 104, pp. 1–5, 2010. View at Google Scholar
  13. Z. Yang, “I-TASSER server for protein 3D structure prediction,” BMC Bioinformatics, vol. 9, article 40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. https://www.ebi.ac.uk/thornton-srv/databases/pdbsum/Generate.html.
  15. H. Kaur, A. Garg, and G. P. S. Raghava, “PEPstr: a de novo method for tertiary structure prediction of small bioactive peptides,” Protein and Peptide Letters, vol. 14, no. 7, pp. 626–631, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. http://www.innovagen.com/custom-peptide-synthesis/peptide-property-calculator/peptide-property-calculator.asp.
  17. J. Kyte and R. F. Doolittle, “A simple method for displaying the hydropathic character of a protein,” Journal of Molecular Biology, vol. 157, no. 1, pp. 105–132, 1982. View at Publisher · View at Google Scholar · View at Scopus
  18. B. G. Pierce, Y. Hourai, and Z. Weng, “Accelerating protein docking in ZDOCK using an advanced 3D convolution library,” PLoS ONE, vol. 6, no. 9, Article ID e24657, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. http://services.mbi.ucla.edu/SAVES/.
  20. T. P. Hopp and K. R. Woods, “Prediction of protein antigenic determinants from amino acid sequences,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 6, pp. 3824–3828, 1981. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Pedotti, L. Simonelli, E. Livoti, and L. Varani, “Computational docking of antibody-antigen complexes, opportunities and pitfalls illustrated by influenza hemagglutinin,” International Journal of Molecular Sciences, vol. 12, no. 1, pp. 226–251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Kunik, B. Peters, and Y. Ofran, “Structural consensus among antibodies defines the antigen binding site,” PLoS Computational Biology, vol. 8, no. 2, Article ID e1002388, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Di and E. H. Kerns, “Solubility issues in early discovery and HTS. Solvent systems and their selection in pharmaceutics and biopharmaceutics,” Biotechnology: Pharmaceutical Aspects, vol. 6, pp. 111–136, 2007. View at Google Scholar
  24. S. Bagby, K. I. Tong, and M. Ikura, “Optimization of protein solubility and stability for protein nuclear magnetic resonance,” Methods in Enzymology, vol. 339, pp. 20–41, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. L. K. Mosavi and Z.-Y. Peng, “Structure-based substitutions for increased solubility of a designed protein,” Protein Engineering, vol. 16, no. 10, pp. 739–745, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. B. A. Andrews, A. S. Schmidt, and J. A. Asenjo, “Correlation for the partition behavior of proteins in aqueous two-phase systems: effect of surface hydrophobicity and charge,” Biotechnology and Bioengineering, vol. 90, no. 3, pp. 380–390, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. S. S. Strickler, A. V. Gribenko, T. R. Keiffer et al., “Protein stability and surface electrostatics: a charged relationship,” Biochemistry, vol. 45, no. 9, pp. 2761–2766, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. S. R. Trevino, J. M. Scholtz, and C. N. Pace, “Amino acid contribution to protein solubility: Asp, Glu , and Ser contribute more favorably than the other hydrophilic amino acids in RNase Sa,” Journal of Molecular Biology, vol. 366, no. 2, pp. 449–460, 2007. View at Publisher · View at Google Scholar · View at Scopus